ExodusPoint Capital Management’s Abeona Therapeutics ABEO Stock Holding History

ExodusPoint Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$551K	Buy	+122,944	New	+$615K	﹤0.01%	1166
2025 Q2	–	Sell	-24,409	Closed	-$116K	–	1412
2025 Q1	$116K	Buy	+24,409	New	+$133K	﹤0.01%	1338
2023 Q2	–	Sell	-120,853	Closed	-$341K	–	1795
2023 Q1	$341K	Buy	120,853 +26,682	+28%	+$69.7K	﹤0.01%	1439
2022 Q4	$290K	Buy	+94,171	New	+$352K	﹤0.01%	1364
2021 Q4	–	Sell	-663	Closed	-$19K	–	2114
2021 Q3	$19K	Sell	663 -3,424	-84%	-$110K	﹤0.01%	2016
2021 Q2	$159K	Buy	4,087 +3,283	+408%	+$134K	﹤0.01%	2046
2021 Q1	$38K	Buy	+804	New	+$44.3K	﹤0.01%	2042
2019 Q3	–	Sell	-704	Closed	-$84K	–	1298
2019 Q2	$84K	Buy	+704	New	+$118K	﹤0.01%	1034

Other funds holding ABEO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ExodusPoint Capital Management's ABEO Position: Q1 2026 in Review

ExodusPoint Capital Management opened a new position in Abeona Therapeutics (ABEO) in Q1 2026: 122,944 shares worth $551K. The stake represents ﹤0.01% of the portfolio and ranks #1166 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in ABEO as recently as Q1 2025.

ExodusPoint Capital Management first reported a position in ABEO in Q2 2019 and has held it in 8 quarters since. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

ExodusPoint Capital Management held 122,944 shares of Abeona Therapeutics worth $551K as of Q1 2026.
Abeona Therapeutics was a new ExodusPoint Capital Management position in Q1 2026.
Abeona Therapeutics made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #1166 holding.
ExodusPoint Capital Management first reported a position in Abeona Therapeutics in Q2 2019 and has held it in 8 quarters since.
108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.